SE9101341D0 - NEW MEDICINAL USE - Google Patents
NEW MEDICINAL USEInfo
- Publication number
- SE9101341D0 SE9101341D0 SE9101341A SE9101341A SE9101341D0 SE 9101341 D0 SE9101341 D0 SE 9101341D0 SE 9101341 A SE9101341 A SE 9101341A SE 9101341 A SE9101341 A SE 9101341A SE 9101341 D0 SE9101341 D0 SE 9101341D0
- Authority
- SE
- Sweden
- Prior art keywords
- medicinal use
- new medicinal
- igf
- nerve regeneration
- new
- Prior art date
Links
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Abstract
The use of IGF-II for preparing a medicament for nerve regeneration; and a method for medical treatment resulting in nerve regeneration, comprising the step of administering to patient in need of such treatment an effective amount of IGF-II.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9101341A SE9101341D0 (en) | 1991-05-03 | 1991-05-03 | NEW MEDICINAL USE |
AU17406/92A AU1740692A (en) | 1991-05-03 | 1992-04-27 | New medicinal use |
PCT/SE1992/000275 WO1992019256A1 (en) | 1991-05-03 | 1992-04-27 | New medicinal use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9101341A SE9101341D0 (en) | 1991-05-03 | 1991-05-03 | NEW MEDICINAL USE |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9101341D0 true SE9101341D0 (en) | 1991-05-03 |
Family
ID=20382638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9101341A SE9101341D0 (en) | 1991-05-03 | 1991-05-03 | NEW MEDICINAL USE |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1740692A (en) |
SE (1) | SE9101341D0 (en) |
WO (1) | WO1992019256A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9310049D0 (en) * | 1993-05-12 | 1993-06-30 | Cancer Res Campaign Tech | Growth factor effects |
CA2176708A1 (en) * | 1993-11-15 | 1995-05-26 | Christopher A. Maack | Method of treating neurological disorders |
GB0011278D0 (en) * | 2000-05-10 | 2000-06-28 | Univ London | Repair of nerve damage |
GB0202906D0 (en) | 2002-02-07 | 2002-03-27 | Univ London | Prevention of myocardial damage |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5093317A (en) * | 1989-06-05 | 1992-03-03 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factor |
JPH0525056A (en) * | 1989-07-27 | 1993-02-02 | Max Planck Inst Fuer Saikaiatorii | Adjustment of nerve growth factor synthesis in central nervous system |
-
1991
- 1991-05-03 SE SE9101341A patent/SE9101341D0/en unknown
-
1992
- 1992-04-27 WO PCT/SE1992/000275 patent/WO1992019256A1/en unknown
- 1992-04-27 AU AU17406/92A patent/AU1740692A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1992019256A1 (en) | 1992-11-12 |
AU1740692A (en) | 1992-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT97552A (en) | METHOD FOR PREPARING FORMS OF DOSAGE FOR THE ADMINISTRATION OF DRUGS FOR THE TREATMENT OF PARKISON'S DISEASE | |
ES2000428T3 (en) | PROCEDURE FOR PRODUCING A MEDICATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE, CONTAINING GALANTAMINE, AND CORRESPONDING MEDICAL DEVICE. | |
HUT63564A (en) | Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine | |
ES2162615T3 (en) | METHOD TO TREAT OR PREVENT TYPE 1 DIABETES THROUGH ORAL INSULIN ADMINISTRATION. | |
SE9401406L (en) | Pharmaceutical products for the cure of tumor diseases as well as a method for the preparation thereof | |
PT913156E (en) | USE OF PROTEIN C ACTIVATED TO TREAT HYPERCERAGULATE STATES ASSOCIATED WITH SEPSIA | |
KR950703951A (en) | ANTIPYRETIC AND ANALGESIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE R-KETOROLAC | |
HU9301253D0 (en) | Medical preparative applicable for treatment of enlarged time of coagulation | |
HU910979D0 (en) | Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives | |
HRP920834B1 (en) | A method for producing an administration and/or dosage form for pharmaceutical active substances using a printing method | |
RU93032613A (en) | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION | |
DK0668077T3 (en) | Products containing G-CSF and TNF-binding protein | |
DE69200711T2 (en) | Pharmaceutical compositions containing fluticasone propionate and oxikonazole or its salt for topical use. | |
SE9101341D0 (en) | NEW MEDICINAL USE | |
IT1159042B (en) | MEDICAL INFUSER DEVICE IMPLANTABLE IN THE BODY OF THE PATIENT | |
AU4058789A (en) | Medicinal drug, method of treatment of human diseases therewith, and method and device for producing and preserving thereof | |
NO890997L (en) | APPLICATOR FOR SKIN CARE, SKIN CARE AND MEDICAL SALVATION. | |
AU1458995A (en) | Device for extracting automatically the needle of a syringe for medical or paramedical use, and particularly, in dentistry | |
NO984196D0 (en) | Procedure for the treatment of substance abuse | |
IT1111893B (en) | CHAIR FOR MEDICAL TREATMENT, IN PARTICULAR DENTAL CHAIR | |
GB2019720A (en) | S-adenosyl-L-homocysteine and salts thereof for use in therapy | |
RU94000695A (en) | Agent showing antiallergic action | |
GR3022945T3 (en) | The use of BMY 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients | |
JO1917B1 (en) | A different way of management of neonatal hyper billirubinemia | |
RU96104613A (en) | METHOD FOR TREATING PATIENTS WITH ENDOCRINE OPHTHALMopathy |